Skip to main content
. 2019 May 2;2019:4047617. doi: 10.1155/2019/4047617

Table 2.

Adverse neurologic events.

No. of patients affected (%) No. of Events ( occurrence rate per IT treatment) Treatment RR 95% CI P Value
Significant Neuro Events 9 (8.26) 11 (3.10)

Overall MTX 1 - -
CYT 1.67 0.19-14.27 0.641
MTX and CYT 1.16 0.50-2.71 0.728

Paresthesias 8 (7.34) 10 (2.82)

MTX 1 - -
CYT 1.67 0.19-14.27 0.64
MTX and CYT 0.64 0.17-2.39 0.51

Paralysis∗∗ 2 (1.83) 3 (0.85)

MTX 1 - -
CYT 8.33 0.52-133.23 0.134
MTX and CYT 0.80 0.05-12.82 0.876

Minor Events 29 (26.61) 109 (30.70)

Overall MTX 1 - -
CYT 1.53 0.75-3.12 0.241
MTX and CYT 0.97 0.66-1.41 0.857

Asthenia 4 (3.67) 10 (2.82)

MTX 1 - -
CYT 2.78 0.56-13.76 0.21
MTX and CYT 0.80 0.26-2.49 0.703

Headache 15 (13.76) 50 (14.08)

MTX 1 - -
CYT 1.23 0.43-3.53 0.694
MTX and CYT 0.68 0.39-1.19 0.180

Back pain 9 (8.26) 18 (5.07)

MTX 1 - -
CYT 2.08 0.44-9.81 0.353
MTX and CYT 1.00 0.40-2.54 0.996

Fever 5 (4.59) 19 (5.35)

MTX 1 - -
CYT 2.78 0.56-13.78 0.211
MTX and CYT 1.47 0.54-3.98 0.447

Nausea 13 (11.93) 48 (13.52)

MTX 1 - -
CYT 0.93 0.21-3.99 0.918
MTX and CYT 1.25 0.69-2.26 0.464

Vomiting 6 (5.50) 32 (9.01)

MTX 1 - -
CYT 1.11 0.25-4.86 0.889
MTX and CYT 0.91 0.45-1.82 0.788

Multiple major or minor events simultaneously are counted only once in overall (overall numbers are therefore less than total of subcategories).

∗∗One patient had both paresthesias and paralysis in two events. To avoid double-counting, these events were included only in paresthesias for the RR calculation.